共 50 条
- [1] No need for systematic switch studies to demonstrate interchangeability of biosimilars [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2022, 11 (01): : 5 - +
- [3] Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products [J]. The AAPS Journal, 2015, 17 : 758 - 768
- [4] Pharmacodynamic Studies to Demonstrate Bioequivalence of Oral Inhalation Products [J]. AAPS JOURNAL, 2015, 17 (03): : 758 - 768
- [5] Focus on biosimilar etanercept - bioequivalence and interchangeability [J]. BIOLOGICS-TARGETS & THERAPY, 2018, 12 : 87 - 95
- [6] Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies [J]. PHARMAZIE, 2010, 65 (03): : 155 - 161
- [7] In Vitro Bioequivalence of Pregabalin Capsules (150 mg): An Alternative to In Vivo Bioequivalence Studies [J]. DISSOLUTION TECHNOLOGIES, 2020, 27 (04): : 25 - 32
- [8] Adjusted indirect comparisons between generics - bioequivalence and interchangeability [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2016, 5 (02): : 53 - 54
- [10] Why bioequivalence and unconditional interchangeability of generic drugs are not the same [J]. GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2013, 2 (02): : 83 - 85